SummaryObesity and the metabolic syndrome (MetS) are risk factors for left ventricular diastolic dysfunction (LVDD). However, little is known about the impact of successful weight reduction (WR) on diastolic function and physical performance.Obese subjects (øBMI 40.2 ± 8.6 kg/m 2 ) underwent a 1-year WR program comprising diet and lifestyle components. Echocardiography and exercise capacity (6-minute walk) were performed at baseline and after 1 year. The distribution of weight reduction was split at the sample median and subjects were dichotomized in "successful WR" (% WR ≥ median, corresponding to a weight loss of 8%) and "failed-WR" (% WR < median).From a total of 188 obese subjects, 71 had LVDD at baseline. Obese patients with successful WR improved their MetS alterations, including fasting glucose, insulin, lipids, adipokines, blood pressure levels, and epicardial fat thickness. (-28 [-54, -4], P < 0.01), and 6-minute walk distance (65 [19, 135], P < 0.01). Improvement of ≥ 2 LVDD criteria was accomplished in 30% of subjects with WR versus 10% without (P = 0.009). Using multivariable regression analysis, reduction of epicardial fat thickness was particularly predictive for the improvement of diastolic function.In summary, in severe obesity, successful long-term WR was associated with improved LV diastolic function and exercise capacity. (Int Heart J 2015; 56: 196-202) Key words: Adiposity, Metabolic syndrome, Diastolic dysfunction, Weight loss O besity and metabolic syndrome (MetS) are increasing in global prevalence. Accompanying these trends there is a concerning shift in the population weight distribution toward the more extreme ends of obesity, given an increased risk for cardiovascular morbidity and mortality that is associated with excess adiposity.1-4) One associated finding is an impairment of cardiac performance leading to myocardial systolic and diastolic dysfunction and clinical symptoms often indistinguishable from heart failure. In fact, evidence of left ventricular diastolic dysfunction (LVDD) is a common finding in the obese, and consequently, obesity is considered a risk factor for diastolic heart failure.
5-9)Although lifestyle modification and weight reduction are routinely recommended to improve symptoms and to reduce cardiovascular risk in the obese with metabolic disorders, their effects on diastolic function and physical performance have been studied only rudimentarily, particularly in adults with severe obesity. Thus, the aim of the present study was to assess the effect of long-term lifestyle and weight reduction programs on these measures in severely obese subjects with varying degrees of MetS.Notably, there is considerable variation in biological determinants, encompassing metabolic and endocrine factors and in the degree of weight loss per se achieved by individuals in response to caloric restriction and physical activity. 10,11) In this regard, it is of interest that several of these biological determinants may independently influence diastolic function or modify the effect of...